Sequential designs for dose escalation studies in oncology

DOI10.1080/03610918.2012.625834zbMATH Open1347.62232OpenAlexW1973822913MaRDI QIDQ4905910FDOQ4905910

Authors: Katrin Roth 

Publication date: 21 February 2013

Published in: Communications in Statistics. Simulation and Computation (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03610918.2012.625834

Recommendations

• Optimal Bayesian-feasible dose escalation for cancer phase I trials
• scientific article; zbMATH DE number 590042
• The construction of optimal designs for dose-escalation studies
• A new look at evaluating MTD designs in cancer research
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer

zbMATH Keywords

optimal designsequential designdose finding studies

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Sequential statistical design (62L05)

Cites Work

• Title not available (Why is that?)
• Bayesian decision procedures based on logistic regression models for dose-finding studies
• Dose finding in drug development.

Cited In (6)

• On optimal designs for clinical trials: an updated review
• Title not available (Why is that?)
• Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
• Adaptive clinical trial designs for phase I cancer studies
• Review of Statistical Treatment for Oncology Dose-Escalation Trial with Prolonged Evaluation Window or Fast Enrollment
• Retrospective Analysis of Sequential Dose‐Finding Designs

This page was built for publication: Sequential designs for dose escalation studies in oncology

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4905910)